GOVX
GeoVax Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.23
−1.72%Year over year
Reported trailing growth
- Revenue
- -100.0%
- EBITDA
- +16.8%
- EBIT
- +18.0%
- EPS
- +77.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- +71.8%
- EPS
- +77.2%
Three-year CAGR
- Revenue
- +212.5%
- EBITDA
- +14.0%
- EBIT
- +13.9%
- Net income
- +14.1%
- EPS
- +81.4%
- Free cash flow
- +12.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026